lenalidomide,rituximab,acalabrutinib
astrazeneca
['lenalidomide', 'ritux', 'acalabrutinib', ' lena', 'lymphoma', 'imab ']
alr (acala, len &amp; ritux) in 1l mcl triplet chemo free 24 pts, med age 64, all st 3/4 tp53 in 29% high responses expected tox: haem, rash med fu 19mo, orr 100%, crr 90%
impressive - esp in tp53 mut pts. #ash22 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.